✦ LIBER ✦

The safety of recombinant factor VIIa: a reply to rebuttal

✍ Scribed by T. Abshire

Book ID: 109148637
Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 72 KB
Volume: 2
Category: Article
ISSN: 1538-7933
DOI: 10.1111/j.1538-7836.2004.01014.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The safety of recombinant factor VIIa: a

The safety of recombinant factor VIIa: a rebuttal

✍ J. Teitel; M-C. Poon 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

Comparative thrombotic event incidence a

Comparative thrombotic event incidence after infusion of recombinant factor VIIa vs. factor VIII inhibitor bypass activity—reply to a rebuttal

✍ L. M. ALEDORT 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

Comparative thrombotic event incidence a

Comparative thrombotic event incidence after infusion of recombinant factor VIIa vs. factor VIII inhibitor bypass activity—reply to a rebuttal

✍ L. M. ALEDORT 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

Comparative thrombotic event incidence a

Comparative thrombotic event incidence after infusion of recombinant factor VIIa versus factor VIII inhibitor bypass activity—a rebuttal

✍ M. MAKRIS; J. J. VAN VEEN 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

Comparative thrombotic event incidence a

Comparative thrombotic event incidence after infusion of recombinant factor VIIa vs. factor VIII inhibitor bypass activity—a rebuttal

✍ S. SALLAH; M. ISAKSEN; S. SEREMETIS; L. PAYNE ROJKJAER 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

Efficacy and safety of repeated perioper

Efficacy and safety of repeated perioperative doses of recombinant factor VIIa in liver transplantation

✍ J. Peter A. Lodge; Sven Jonas; Robert M. Jones; Michael Olausson; José Mir-Palla 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB 👁 1 views

## Patients undergoing orthotopic liver transplantation (OLT) have excessive blood loss during surgery that requires blood transfusions, leading to increased postoperative morbidity and mortality. We studied the efficacy and safety of activated recombinant factor VII (rFVIIa) in reducing transfusio